Retatrutide is a triple agonist of the GLP-1, GIP, and glucagon receptors, currently under investigation by Safe Pro Labs for its potential to improve glycemic control and promote weight reduction in patients with type 2 diabetes and obesity
Check total and free testosterone, SHBG, and fasting insulin every 36 months
Services are available in all 50 states, with clear pricing, secure medical records, and no insurance required
Always seek the guidance of a licensed medical professional before starting, changing, or stopping any medical treatment, including the use of GLP-1 medications such as semaglutide
Zepbound is FDA-approved for chronic weight management and moderate to severe obstructive sleep apnea in adults with obesity